Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Through a series of expert-led local lives, simulcasts, and an on-demand webcast, learn how treatment sequencing for patients with HER2-positive metastatic breast cancer can be optimized, especially for those in the community setting.

Share

Program Content

Activities

Sequencing for HER2-Positive MBC
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2024

Expires: March 12, 2025

Activities

Treating HER2pos mBC
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2024

Expires: April 03, 2025

Faculty

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

cover img faculity

Ruta D Rao, MD

Professor of Medicine
Medical Director, Rush University Cancer Center
Rush University Medical Center
Chicago, Illinois

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.